NCT03808181View on ClinicalTrials.gov

An Open, Single-arm, Multi Centre Pilot Investigation to Evaluate the Debriding Effect of ChloraSolv® on Chronic Wounds

NACompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

January 31, 2019

Primary Completion Date

April 30, 2020

Study Completion Date

June 30, 2020

Conditions
Chronic Ulcer at Lower Leg
Interventions
DEVICE

ChloraSolv

Weekly application of ChloraSolv for 6 weeks

Trial Locations (9)

11883

Sårcentrum Södersjukhuset Stockholm, Stockholm

40545

Carlanderska Sjukhuset, Gothenburg

41345

Medicinkliniken, Diabetescentrum, Sahlgrenska Universitetssjukhuset, Gothenburg

41665

Närhälsan Olskroken Primary Care Center, Gothenburg

42677

Wästerläkarna Primary Care Center, Gothenburg

43180

Dept of Orthopaedic Surgery, Mölndal

54185

Hudmottagningen Skaraborgs Sjukhus, Skövde

63188

Primary Care Center Tunafors, Eskilstuna

Unknown

Department of Endocrinology Skåne University Hospital Malmö, Malmo

All Listed Sponsors
lead

RLS Global

INDUSTRY

NCT03808181 - An Open, Single-arm, Multi Centre Pilot Investigation to Evaluate the Debriding Effect of ChloraSolv® on Chronic Wounds | Biotech Hunter | Biotech Hunter